Suzhou Porton Biologics Partners with Bennu Biotherapeutics for Gene and Cell Therapies
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has entered into a...
Bennu Biotherapeutics
Bennu Biotherapeutics Raises Over RMB100m in Angel+ Round for Global Pipeline Development
Shanghai-based cell therapy specialist Bennu Biotherapeutics has raised over RMB100 million (USD14.8 million) in an...